Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4751701
Max Phase: Preclinical
Molecular Formula: C39H44F3IN6O10
Molecular Weight: 940.71
Molecule Type: Unknown
Associated Items:
ID: ALA4751701
Max Phase: Preclinical
Molecular Formula: C39H44F3IN6O10
Molecular Weight: 940.71
Molecule Type: Unknown
Associated Items:
Canonical SMILES: O=C1CCC(N2C(=O)c3ccc(NCCOCCOCCOCCOCCNCCCONC(=O)c4ccc(F)c(F)c4Nc4ccc(I)cc4F)cc3C2=O)C(=O)N1
Standard InChI: InChI=1S/C39H44F3IN6O10/c40-29-6-5-27(35(34(29)42)46-31-7-2-24(43)22-30(31)41)36(51)48-59-13-1-10-44-11-14-55-16-18-57-20-21-58-19-17-56-15-12-45-25-3-4-26-28(23-25)39(54)49(38(26)53)32-8-9-33(50)47-37(32)52/h2-7,22-23,32,44-46H,1,8-21H2,(H,48,51)(H,47,50,52)
Standard InChI Key: NDVKGLATBKSGPC-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 940.71 | Molecular Weight (Monoisotopic): 940.2116 | AlogP: 3.67 | #Rotatable Bonds: 25 |
Polar Surface Area: 194.89 | Molecular Species: BASE | HBA: 13 | HBD: 5 |
#RO5 Violations: 2 | HBA (Lipinski): 16 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 11.45 | CX Basic pKa: 9.40 | CX LogP: 4.12 | CX LogD: 2.14 |
Aromatic Rings: 3 | Heavy Atoms: 59 | QED Weighted: 0.04 | Np Likeness Score: -1.03 |
1. Hu J,Wei J,Yim H,Wang L,Xie L,Jin MS,Kabir M,Qin L,Chen X,Liu J,Jin J. (2020) Potent and Selective Mitogen-Activated Protein Kinase Kinase 1/2 (MEK1/2) Heterobifunctional Small-molecule Degraders., 63 (24.0): [PMID:33284613] [10.1021/acs.jmedchem.0c01609] |
Source(1):